Drug:
Reaction: DRUG INEFFECTIVE
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25491854 |
CN |
73 | 2 |
Hospitalisation, Disease recurrence, Dyspnoea, Chest discomfort, Abdominal distension, Pain, Discomfort, Fatigue, Drug ineffective, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
2 | 25491912 |
US |
2 | |
Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
3 | 25492022 |
US |
66 | 2 |
Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
4 | 25492333 |
US |
1 | |
Drug ineffective, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
5 | 25492338 |
US |
||
Drug ineffective, |
||||
ONABOTULINUMTOXINA, |
||||
6 | 25492405 |
DE |
54 | 2 |
Noninfective oophoritis, Alopecia, Tremor, Drug ineffective, Suspected product quality issue, |
||||
LEVOTHYROXINE SODIUM, |
||||
7 | 25492434 |
US |
2 | |
Drug ineffective, Off label use, Arthralgia, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
8 | 25492439 |
CA |
61 | 2 |
Psoriatic arthropathy, Drug ineffective, General physical health deterioration, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
9 | 25492442 |
US |
2 | |
Urticaria, Drug ineffective, Scab, |
||||
OMALIZUMAB, |
||||
10 | 25492484 |
US |
45 | 2 |
Psoriatic arthropathy, Drug ineffective, Product dose omission issue, Device malfunction, |
||||
GUSELKUMAB, |
||||
11 | 25492518 |
US |
63 | 2 |
Malignant neoplasm progression, Off label use, Drug ineffective, |
||||
ABEMACICLIB, |
||||
12 | 25492555 |
US |
||
Myalgia, Vision blurred, Insomnia, Headache, Diarrhoea, Drug ineffective, |
||||
VIBEGRON, |
||||
13 | 25492557 |
CA |
21 | 1 |
Haematochezia, Frequent bowel movements, Drug ineffective, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, ETRASIMOD, BUDESONIDE, PREDNISONE, |
||||
14 | 25492559 |
US |
2 | |
Drug ineffective, Product packaging quantity issue, Product container issue, Product use complaint, |
||||
KETOTIFEN FUMARATE, |
||||
15 | 25492561 |
IL |
||
Serotonin syndrome, Accidental overdose, Fall, Drug ineffective, |
||||
PREGABALIN, BUPRENORPHINE, |
||||
16 | 25492596 |
US |
||
Drug ineffective, Speech disorder, Dyskinesia, Drooling, |
||||
VALBENAZINE, |
||||
17 | 25492621 |
US |
2 | |
Neoplasm malignant, Product container issue, Fatigue, Dry eye, Drug ineffective, Glaucoma, Plastic surgery, |
||||
CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80, |
||||
18 | 25492663 |
US |
54 | 2 |
Drug ineffective, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
19 | 25492805 |
HR |
48 | 1 |
Colitis ulcerative, Drug ineffective, |
||||
VEDOLIZUMAB, |
||||
20 | 25492809 |
IT |
70 | 2 |
Drug ineffective, Disseminated mucormycosis, H1N1 influenza, Infection, |
||||
BENDAMUSTINE HCL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, VENETOCLAX, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, IDELALISIB, FLUCONAZOLE, IBRUTINIB, MEROPENEM, ITRACONAZOLE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, DAPTOMYCIN, AMPHOTERICIN B, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
21 | 25492831 |
US |
1 | |
Off label use, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
22 | 25492856 |
US |
76 | 1 |
Blood product transfusion dependent, Drug ineffective, |
||||
VENETOCLAX, CYCLOBENZAPRINE, COLCHICINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ALLOPURINOL, AMLODIPINE, AZACITIDINE, HYDROCHLOROTHIAZIDE, TELMISARTAN, AMOXICILLIN, |
||||
23 | 25492875 |
US |
29 | 2 |
Treatment noncompliance, Drug ineffective, |
||||
VALPROIC ACID, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, OXCARBAZEPINE, METHYLPREDNISOLONE, PHENYTOIN, PHENOBARBITAL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, RITUXIMAB, |
||||
24 | 25492895 |
US |
2 | |
Cerebrovascular accident, Cardiac disorder, Drug ineffective, |
||||
EVOLOCUMAB, |
||||
25 | 25492900 |
US |
38 | 2 |
Abortion induced, Pregnancy with contraceptive device, Drug ineffective, Intentional device use issue, Off label use, |
||||
COPPER, |
||||
26 | 25493020 |
US |
||
Drug ineffective, |
||||
DEUTETRABENAZINE, |
||||
27 | 25493084 |
US |
2 | |
Drug ineffective, |
||||
MIDAZOLAM, |
||||
28 | 25493102 |
US |
20 | 1 |
Adverse event, Drug ineffective, Product substitution issue, |
||||
PHENYTOIN, PHENYTOIN, PHENYTOIN, PHENYTOIN, |
||||
29 | 25493143 |
SK |
28 | 2 |
Drug ineffective, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ACYCLOVIR, ACYCLOVIR, ACYCLOVIR, ACYCLOVIR, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
30 | 25493144 |
US |
40 | 1 |
Drug ineffective, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DASATINIB, DASATINIB, DASATINIB, DASATINIB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, |
||||
31 | 25493145 |
US |
60 | 2 |
Drug ineffective, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, PREDNISONE, FLUDARABINE PHOSPHATE, OCTREOTIDE ACETATE, OCTREOTIDE, GONADOTROPHIN, CHORIONIC, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BUDESONIDE, DASATINIB, DASATINIB, INFLIXIMAB-DYYB, |
||||
32 | 25493148 |
IN |
24 | 2 |
Drug ineffective, Palmar-plantar erythrodysaesthesia syndrome, |
||||
METHOTREXATE, METHOTREXATE SODIUM, CAPECITABINE, |
||||
33 | 25493149 |
IT |
75 | 1 |
Electrocardiogram QT prolonged, Drug interaction, Drug ineffective, |
||||
ABIRATERONE ACETATE, ABIRATERONE, ABIRATERONE ACETATE, ABIRATERONE, ENZALUTAMIDE, ENZALUTAMIDE, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
34 | 25493156 |
FR |
1 | |
Septic shock, Escherichia infection, Campylobacter infection, Myelodysplastic syndrome, Gene mutation, Multiple organ dysfunction syndrome, Crohn^s disease, Pulmonary embolism, Splenic embolism, Thrombocytopenia, Acute kidney injury, Drug ineffective, |
||||
PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, APIXABAN, APIXABAN, APIXABAN, APIXABAN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, PEGCETACOPLAN, PEGCETACOPLAN, PEGCETACOPLAN, PEGCETACOPLAN, DEFERASIROX, DEFERASIROX, DEFERASIROX, DEFERASIROX, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
35 | 25493232 |
US |
5 | 2 |
Drug ineffective, |
||||
VALBENAZINE, |
||||
36 | 25493240 |
US |
8 | 2 |
Fatigue, Adverse event, Drug ineffective, |
||||
STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, CLOBAZAM, CANNABIDIOL, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
37 | 25493243 |
US |
64 | 1 |
Knee arthroplasty, Drug ineffective, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
38 | 25493263 |
US |
29 | 2 |
Infertility female, Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Pregnancy with contraceptive device, Drug ineffective, Depression, Anxiety, Pelvic pain, Vaginal haemorrhage, Pain, Discomfort, Infection, |
||||
COPPER, |
||||
39 | 25493266 |
US |
26 | 2 |
Haemorrhage in pregnancy, Device breakage, Foreign body in reproductive tract, Complication of device removal, Pregnancy with contraceptive device, Drug ineffective, Emotional distress, Anxiety, |
||||
COPPER, |
||||
40 | 25493268 |
US |
68 | 2 |
Drug ineffective, Extra dose administered, Product container issue, |
||||
TRAVOPROST, TRAVOPROST (ISOMER FREE), LATANOPROST, |
||||
41 | 25493311 |
US |
76 | 1 |
Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
42 | 25493319 |
AE |
26 | 1 |
Vomiting, Nausea, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
43 | 25493330 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
44 | 25493359 |
US |
65 | 2 |
Cardiac arrest, Myocardial depression, Drug ineffective, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, PHENYTOIN, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PROPOFOL, PHENOBARBITAL, LORAZEPAM, FOSPHENYTOIN, FOSPHENYTOIN SODIUM, |
||||
45 | 25493361 |
GB |
||
Drug interaction, Vomiting, Diarrhoea, Drug ineffective, |
||||
RIVAROXABAN, TIRZEPATIDE, |
||||
46 | 25493387 |
US |
11 | |
Diabetic ketoacidosis, Glycosylated haemoglobin increased, Drug ineffective, |
||||
TEPLIZUMAB-MZWV, |
||||
47 | 25493398 |
GB |
79 | 1 |
Drug ineffective, |
||||
RIFAMPIN, ISONIAZID, METHOTREXATE, METHOTREXATE SODIUM, |
||||
48 | 25493402 |
US |
62 | 2 |
Pneumonia, Sleep disorder due to a general medical condition, Loss of personal independence in daily activities, Dry eye, Asthma, Drug ineffective, |
||||
DUPILUMAB, |
||||
49 | 25493433 |
CN |
76 | 2 |
Drug ineffective, |
||||
AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, ALBUMIN HUMAN, |
||||
50 | 25493448 |
US |
54 | 2 |
Drug ineffective, Off label use, |
||||
NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, NITROGLYCERIN, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, RANOLAZINE, RANOLAZINE, RANOLAZINE, RANOLAZINE, |
||||
51 | 25493449 |
CA |
2 | |
Colitis ulcerative, Condition aggravated, Dyspepsia, Decreased appetite, Face injury, Gastritis, Scar, Gastric haemorrhage, Acne, Alopecia, Drug ineffective, |
||||
ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, |
||||
52 | 25493452 |
US |
15 | 1 |
Aspergillus infection, Duodenal perforation, Drug ineffective, Organ failure, Unresponsive to stimuli, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, MICAFUNGIN, MICAFUNGIN SODIUM, MICAFUNGIN, MICAFUNGIN SODIUM, MICAFUNGIN, MICAFUNGIN SODIUM, MICAFUNGIN, MICAFUNGIN SODIUM, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
53 | 25493476 |
US |
||
Drug ineffective, |
||||
DULAGLUTIDE, |
||||
54 | 25493481 |
US |
60 | 2 |
Intercepted product selection error, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
55 | 25493485 |
US |
1 | |
Drug ineffective, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
56 | 25493540 |
US |
43 | 1 |
Acute respiratory failure, Drug ineffective, Metabolic encephalopathy, Septic shock, Rhabdomyolysis, Acute kidney injury, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, |
||||
57 | 25493584 |
US |
2 | |
Mental disorder, Drug ineffective, |
||||
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, METHOCARBAMOL, METHOCARBAMOL, METHOCARBAMOL, METHOCARBAMOL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, MELATONIN, MELATONIN, MELATONIN, MELATONIN, FAMOTIDINE, FAMOTIDINE, FAMOTIDINE, FAMOTIDINE, ESCITALOPRAM, ESCITALOPRAM, ESCITALOPRAM, ESCITALOPRAM, EPINEPHRINE, EPINEPHRINE, EPINEPHRINE, EPINEPHRINE, |
||||
58 | 25493597 |
US |
60 | 2 |
Hepatic cancer, Thyroid disorder, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
59 | 25493604 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
60 | 25493605 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
61 | 25493613 |
US |
2 | |
Drug ineffective, |
||||
BELIMUMAB, HYDROXYCHLOROQUINE, |
||||
62 | 25493628 |
IT |
83 | 2 |
Drug ineffective, |
||||
IMATINIB, BOSUTINIB, |
||||
63 | 25493672 |
PL |
55 | 1 |
Drug ineffective, Somnolence, Confusional state, Dizziness, Ataxia, Vision blurred, |
||||
CARBAMAZEPINE, PHENYTOIN, CLONAZEPAM, GABAPENTIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
64 | 25493676 |
GB |
20 | 2 |
Drug ineffective, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZATHIOPRINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
65 | 25493688 |
ES |
||
Death, Drug ineffective, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
66 | 25493693 |
FR |
2 | |
Drug ineffective, |
||||
LACOSAMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, ZONISAMIDE, |
||||
67 | 25493703 |
ES |
71 | 1 |
Drug ineffective, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), CEFTAROLINE FOSAMIL, CYPROHEPTADINE HYDROCHLORIDE, |
||||
68 | 25493710 |
US |
63 | 1 |
Drug ineffective, |
||||
AMIODARONE HYDROCHLORIDE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
69 | 25493719 |
US |
46 | 1 |
Drug ineffective, |
||||
KETOTIFEN FUMARATE, |
||||
70 | 25493735 |
US |
74 | 2 |
Fungal infection, Injection site pain, Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
71 | 25493889 |
US |
56 | 2 |
Arthralgia, Hot flush, Condition aggravated, Drug ineffective, Product substitution issue, |
||||
ESTRADIOL, PROGESTERONE, |
||||
72 | 25493902 |
US |
2 | |
Psoriatic arthropathy, Drug ineffective, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
73 | 25493920 |
US |
2 | |
Drug ineffective, |
||||
74 | 25493967 |
US |
2 | |
Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, |
||||
75 | 25493987 |
US |
82 | 1 |
Cardiac failure congestive, Blood pressure abnormal, Abnormal behaviour, Decreased appetite, Gait inability, Dyskinesia, Fatigue, Somnolence, Drug ineffective, Therapy interrupted, Product use in unapproved indication, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
76 | 25494022 |
US |
2 | |
Colitis, Drug ineffective, |
||||
RISANKIZUMAB-RZAA, |
||||
77 | 25494035 |
IT |
29 | 2 |
Drug ineffective, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, RITUXIMAB, |
||||
78 | 25494053 |
CA |
43 | 2 |
Blepharospasm, Contraindicated product administered, Decreased appetite, Drug ineffective, Epilepsy, Gastrooesophageal reflux disease, Hypoaesthesia, Malaise, Memory impairment, Migraine, Off label use, Pain, Product quality issue, Product use in unapproved indication, Rheumatic fever, Rheumatoid factor positive, Swollen joint count increased, Taste disorder, Treatment failure, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CAFFEINE CITRATE, CALCIUM GLUCONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, |
||||
79 | 25494155 |
FR |
2 | |
Drug ineffective, |
||||
VALPROIC ACID, CARBAMAZEPINE, PHENYTOIN, |
||||
80 | 25494162 |
US |
1 | |
Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
81 | 25494164 |
AU |
||
Acute psychosis, Treatment noncompliance, Drug ineffective, Inability to afford medication, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
82 | 25494174 |
US |
79 | 2 |
Drug ineffective, Musculoskeletal stiffness, |
||||
TOFACITINIB, |
||||
83 | 25494188 |
US |
67 | 2 |
Urinary tract infection, Drug ineffective, Asthenia, Therapeutic response unexpected, Blood pressure increased, |
||||
TOFACITINIB, PREDNISONE, |
||||
84 | 25494192 |
US |
2 | |
Drug ineffective, |
||||
ABROCITINIB, |
||||
85 | 25494196 |
US |
2 | |
Hallucination, visual, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
86 | 25494207 |
US |
||
Drug ineffective, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
87 | 25494208 |
US |
||
Product after taste, Drug ineffective, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
88 | 25494222 |
FR |
2 | |
Drug ineffective, |
||||
SERTRALINE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, ZONISAMIDE, CARBAMAZEPINE, CARBAMAZEPINE, PERAMPANEL, PERAMPANEL, PHENYTOIN, CANNABIDIOL, CLOBAZAM, ESLICARBAZEPINE ACETATE, |
||||
89 | 25494227 |
US |
||
Drug ineffective, Incorrect dose administered, Dysgeusia, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
90 | 25494229 |
US |
72 | 2 |
Drug ineffective, Incorrect product administration duration, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
91 | 25494230 |
US |
||
Nausea, Drug ineffective, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
92 | 25494232 |
US |
||
Drug ineffective, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
93 | 25494233 |
US |
||
Drug ineffective, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
94 | 25494241 |
US |
1 | |
Drug ineffective, |
||||
EPINEPHRINE, ADRENALINUM, COAGULATION FACTOR VIIA RECOMBINANT HUMAN, |
||||
95 | 25494244 |
US |
||
Drug ineffective, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
96 | 25494249 |
FI |
2 | |
Drug ineffective, Therapeutic product effect incomplete, Cholangitis, Cholestasis, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PHENYTOIN, TOPIRAMATE, TOPIRAMATE SPINKLE, VALPROIC ACID, LACOSAMIDE, PHENOBARBITAL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LEUCOVORIN CALCIUM, |
||||
97 | 25494321 |
US |
8 | 1 |
Tubulointerstitial nephritis, Drug ineffective, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFEPIME HYDROCHLORIDE, CEFEPIME, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, CARVEDILOL, CARVEDILOL, CARVEDILOL, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, NIFEDIPINE, NIFEDIPINE, NIFEDIPINE, NIFEDIPINE, CEFAZOLIN SODIUM, CEFAZOLIN, CEFAZOLIN SODIUM, CEFAZOLIN, CEFAZOLIN SODIUM, CEFAZOLIN, CEFAZOLIN SODIUM, CEFAZOLIN, |
||||
98 | 25494324 |
US |
||
Drug ineffective, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
99 | 25494340 |
IT |
||
Cholangitis sclerosing, Autoimmune cholangitis, Drug ineffective, Off label use, |
||||
INFLIXIMAB, |
||||
100 | 25494345 |
GB |
||
Lupus nephritis, Drug ineffective, Drug ineffective for unapproved indication, |
||||
METHOTREXATE, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29